Bioscience

TGen finds protein inhibitor revives chemotherapy for ovarian patients

July 8, 2010

By Flinn Foundation

[Source: TGen] – Investigators at the Translational Genomics Research Institute (TGen) have discovered a way that may help ovarian cancer patients who no longer respond to conventional chemotherapy.

A scientific paper that will be published in the September issue of the journal Gynecologic Oncology describes how the inhibition of a protein, CHEK1, may be an effective element to incorporate into therapies for women with ovarian cancer.

For more information: TGen finds protein inhibitor revives chemotherapy for ovarian patients